Add to ORKGIdentifying cancer mutation targets across thousands of samples: MuteProc, a high throughput mutation analysis pipelin
Large-scale genomic analyses of tumor cells have revealed many genetic alterations present in cancer...
<p>Large-scale tumor genome sequencing projects have revealed a complex landscape of genomic mutatio...
Background: An increasing number of anti-cancer therapeutic agents target specific mutant proteins t...
high-throughput cell line drug screening studies to identify candidate therapeutic agents in head an...
Distinguishing between driver and passenger mutations in individual cancer genomes by ysi
A computational method for clinically relevant cancer stratification and driver mutation module disc...
Exome sequencing reveals a potential mutational trajectory and treatments for a specific pancreatic ...
BACKGROUND: Detection of critical cancer gene mutations in clinical tumor specimens may predict pat...
Background: An increasing number of anti-cancer therapeutic agents target specific mutant proteins t...
Integrated analysis of recurrent properties of cancer genes to identify novel driver
It is well established that a plethora of mutations that occur in oncogenes and tumor-suppressor gen...
Somatic mutation and gene expression dysregulation are considered two major tumorigenesis factors. W...
Copyright © 2015 George J. Burghel et al. This is an open access article distributed under the Creat...
The Cancer Genome Atlas (TCGA) cancer genomics dataset includes over 10,000 tumor-normal exome pairs...
Gene expression anti-profiles as a basis for accurate universal cancer signature
Large-scale genomic analyses of tumor cells have revealed many genetic alterations present in cancer...
<p>Large-scale tumor genome sequencing projects have revealed a complex landscape of genomic mutatio...
Background: An increasing number of anti-cancer therapeutic agents target specific mutant proteins t...
high-throughput cell line drug screening studies to identify candidate therapeutic agents in head an...
Distinguishing between driver and passenger mutations in individual cancer genomes by ysi
A computational method for clinically relevant cancer stratification and driver mutation module disc...
Exome sequencing reveals a potential mutational trajectory and treatments for a specific pancreatic ...
BACKGROUND: Detection of critical cancer gene mutations in clinical tumor specimens may predict pat...
Background: An increasing number of anti-cancer therapeutic agents target specific mutant proteins t...
Integrated analysis of recurrent properties of cancer genes to identify novel driver
It is well established that a plethora of mutations that occur in oncogenes and tumor-suppressor gen...
Somatic mutation and gene expression dysregulation are considered two major tumorigenesis factors. W...
Copyright © 2015 George J. Burghel et al. This is an open access article distributed under the Creat...
The Cancer Genome Atlas (TCGA) cancer genomics dataset includes over 10,000 tumor-normal exome pairs...
Gene expression anti-profiles as a basis for accurate universal cancer signature
Large-scale genomic analyses of tumor cells have revealed many genetic alterations present in cancer...
<p>Large-scale tumor genome sequencing projects have revealed a complex landscape of genomic mutatio...
Background: An increasing number of anti-cancer therapeutic agents target specific mutant proteins t...